Read More 24 minute read Earnings Markets News Pre-Market Outlook Earnings Scheduled For August 4, 2021 By Benzinga Insights Today, 2:06 PM Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. ABC
Read More 2 minute read Movers Analyzing Macerich’s Unusual Options Activity By Benzinga Insights Today, 2:06 PM Macerich (NYSE:MAC) shares experienced unusual options activity on Friday. The stock price moved down to $16.44 following the option alert. MAC
Read More 2 minute read Markets Options Unusual Options Activity Insight: Macerich By Benzinga Insights Today, 2:06 PM Shares of Macerich (NYSE:MAC) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $16.62. MAC
Read More 2 minute read Markets Options Understanding Macerich’s Unusual Options Activity By Benzinga Insights Today, 2:06 PM Macerich (NYSE:MAC) shares experienced unusual options activity on Monday. The stock price moved down to $15.66 following the option alert. MAC
Read More 3 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For July 15, 2021 By Benzinga Insights Today, 2:06 PM AMTX
Read More 3 minute read Earnings Eurozone Futures Global Markets News Penny Stocks Pre-Market Outlook Small Cap A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Economic Data By Lisa Levin Today, 2:06 PM Pre-open movers AA
Read More 1 minute read Analyst Ratings News Upgrades Jefferies Upgrades Macerich to Hold By Benzinga Newsdesk Today, 2:06 PM Jefferies analyst Linda Tsai upgrades Macerich (NYSE:MAC) from Underperform to Hold. MAC
Read More 2 minute read Markets Options Understanding Macerich’s Unusual Options Activity By Benzinga Insights Today, 2:06 PM Shares of Macerich (NYSE:MAC) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved down to $17.23. MAC
Read More 1 minute read Analyst Ratings News Price Target Upgrades Deutsche Bank Upgrades Macerich to Buy, Raises Price Target to $24 By Benzinga Newsdesk Today, 2:06 PM Deutsche Bank analyst Derek Johnston upgrades Macerich (NYSE:MAC) from Hold to Buy and raises the price target from $20 to $24. MAC
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Underweight on Macerich, Raises Price Target to $13 By Benzinga Newsdesk Today, 2:06 PM Morgan Stanley analyst Richard Hill maintains Macerich (NYSE:MAC) with a Underweight and raises the price target from $12 to $13. MAC